Test Price
1,500 AED✅ Home Collection Available
Immunosuppressant Drug Profile 3 (ISP3) – Therapeutic Drug Monitoring in Dubai, UAE
Executive Summary & Core Metrics
99.9% Sensitivity ISO 9001:2015 VIP Mobile Phlebotomy
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO accredited LC‑MS/MS processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (8 AM – 11 PM).
Clinical Guidance: Complimentary telephonic post‑test result interpretation with a DHA‑licensed physician.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Immunosuppressant Drug Profile 3 (ISP3) test uses liquid chromatography‑tandem mass spectrometry (LC‑MS/MS) to precisely measure trough blood levels of critical immunosuppressants including tacrolimus, cyclosporin, sirolimus, everolimus, and mycophenolic acid. Accurate monitoring prevents organ rejection and drug toxicity in post‑transplant patients and those on long‑term immunosuppressive therapy.
| Feature | Our ISP3 Test | Closest Alternative |
|---|---|---|
| Methodology | LC‑MS/MS (Tandem Mass Spectrometry) | Immunoassay (cross‑reactivity risks) |
| Clinical Precision | Trough‑specific guidance, drug‑specific metabolite distinction | Generic total drug concentration |
| Turnaround Time | Same‑day report (sample by 5 pm) | 24‑72 hours |
| Regulatory Alignment | DHA, ISO 9001:2015, PDPL compliant | Variable |
Physician Insight & Safety Protocols
“Therapeutic drug monitoring is the cornerstone of safe immunosuppression. Trough levels must always be interpreted alongside renal function, blood counts, and clinical signs. Never adjust your medication without consulting your physician.”
— Dr. Ajay Singh, General Practitioner, DHA License: 36234132
Medication Advisory
⚠️ Do not discontinue any prescribed immunosuppressant medication without explicit instruction from your doctor. Abrupt cessation can lead to life‑threatening organ rejection.
Exclusion Criteria & ER Red Flags
- Exclusion: Active severe infection, uncontrolled bleeding diathesis, known allergy to EDTA anticoagulant.
- Exclusion: Patient unable to adhere to trough sampling window (±30 min of next dose).
- Red Flag: New onset tremors, confusion, seizures (calcineurin inhibitor toxicity) — seek immediate medical attention.
- Red Flag: Fever, graft tenderness, sudden decrease in urine output (possible acute rejection) — go to ER.
- Red Flag: Any sample collected more than 2 hours post‑trough or with undocumented dosing time will be rejected.
Patient FAQ & Clinical Guidance
1. What is the ISP3 and why do I need it?
This LC‑MS/MS panel measures trough blood levels of immunosuppressants (tacrolimus, cyclosporin, sirolimus, everolimus, mycophenolic acid) to prevent organ rejection and drug toxicity. Regular monitoring ensures your drug dose stays within the therapeutic range, protecting your transplanted organ while minimising side effects.
2. How should I prepare for the blood collection?
Collect blood exactly before your next scheduled dose (trough level), and clearly write the last dose time and sampling time on the tube. Do not take your morning dose until after the sample is drawn, unless instructed otherwise. Bring your medication list and any recent dose changes to the phlebotomist’s attention.
3. When will I receive my results and what next?
Results are delivered same day if the sample arrives at our lab by 5 pm, enabling rapid dose adjustments under your physician’s guidance. You will receive a secure digital report, and our clinical team is available for a complimentary tele‑consultation to explain the values in the context of your overall health.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. Your medical data is encrypted, access‑controlled, and processed strictly for diagnostic purposes.
Clinical & Logistical Metadata
| Test Name | Immunosuppressant Drug Profile 3 (ISP3) |
| Price (AED) | 1,500 |
| Turnaround Time | 24 hours (results same day if sample received before 5 PM) |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) |
| Methodology Used | LC‑MS/MS (Tandem Mass Spectrometry) |
| ICD-10-CM Code | Z51.81 |
| LOINC Code | 101658-9 |
| DHA Facility License & Lab Address |
License No. 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians